HNPOLY(SZ:300630)2021-04-23 16:00Financial Performance - The company's revenue for Q1 2021 was ¥273,392,371.83, representing a 60.03% increase compared to ¥170,838,521.57 in the same period last year[10] - Net profit attributable to shareholders was ¥121,239,486.28, up 51.40% from ¥80,080,883.58 year-on-year[10] - Basic earnings per share rose to ¥0.24, a 33.33% increase from ¥0.18 in the same period last year[10] - The company achieved total operating revenue of CNY 273,392,371.83 in Q1 2021, representing a year-on-year growth of 60.03%[23] - The net profit attributable to shareholders increased by 51.40% year-on-year, reaching CNY 121,239,486.28[23] - The total comprehensive income for the period was CNY 121,239,486.28, compared to CNY 80,080,883.58 in the previous period, representing an increase of approximately 51.5%[70] Cash Flow and Liquidity - The net cash flow from operating activities increased by 76.17%, reaching ¥11,299,484.87 compared to ¥6,413,837.93 in the previous year[10] - Cash and cash equivalents rose by 140.41% to CNY 857,425,098.72, primarily due to the proceeds from convertible bond issuance[22] - The company’s cash received from sales increased by 40.66% to CNY 257,236,019.60, indicating improved cash flow from operations[22] - The total cash inflow from operating activities was CNY 271,247,055.22, up from CNY 196,652,351.12, which is an increase of approximately 37.9%[82] - The total cash and cash equivalents at the end of the period reached 856,254,087.18 CNY, up from 108,358,597.61 CNY in the previous period, showing improved liquidity[84] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,987,868,404.28, reflecting a 30.49% increase from ¥3,055,999,316.62 at the end of the previous year[10] - The company reported a total cash inflow from operating activities of CNY 271,247,055.22, up from CNY 196,652,351.12, which is an increase of approximately 37.9%[82] - Current assets totaled approximately CNY 1.71 billion, a significant increase from CNY 1.23 billion as of December 31, 2020, representing a growth of about 38.5%[45] - Total liabilities increased to CNY 1.58 billion from CNY 1.02 billion, reflecting a growth of approximately 55%[51] - The company's equity attributable to shareholders rose to CNY 2.41 billion from CNY 2.04 billion, an increase of about 18.2%[54] Research and Development - Research and development expenses increased by 107.40% to CNY 50,208,146.21, reflecting the company's commitment to enhancing its R&D capabilities[22] - Research and development expenses for the quarter were ¥50,208,146.21, compared to ¥24,208,482.51 in the previous year, showing an increase of approximately 107.5%[64] - Research and development expenses increased to CNY 27,508,965.83 from CNY 14,509,310.61, marking an increase of approximately 89.6%[71] Market and Growth Strategy - The company signed significant orders and continued to expand its domestic and international market presence[23] - The company plans to continue strengthening its competitive position in niche markets while expanding its product sales domestically and internationally[23] - The company plans to continue expanding its market presence and investing in new product development to sustain growth momentum in the upcoming quarters[63] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 16,397[13] - The largest shareholder, Fan Minhua, holds 33.88% of the shares, totaling 148,083,509 shares[13] Government Support and Compliance - The company received government subsidies totaling ¥3,292,648.97 during the reporting period[10] - The company has no significant changes in project feasibility and no issues with the use of raised funds[35] - The company has no violations regarding external guarantees during the reporting period[39] - The company has no non-operating occupation of funds by controlling shareholders and their affiliates during the reporting period[40]